Published Aug 08, 2018

Harbour BioMed inks $350 million deal for rights to A167

Member News
Copy The Link to the  Article
Harbour BioMed inks $350 million deal for rights to A167
Copy The Link to the  Article

Related or similar articles

View more News
May 12, 2025

Leasing / Subleasing vs. Shared Labs: Why Labshares is the Capital-Efficient Choice for Biotechs

Blog Posts
June 18, 2024

Labshares Announces Key Leadership Additions: Devon Lagasse Joins as VP of Growth and Emma Orfanos Is Promoted to Manager of Business Development

Press Releases
April 8, 2025

Trapped in Too Much Lab Space? You’re Not Alone—And There’s a Smarter Option

Blog Posts